Why did the Senate block restraining Trump on Iran strikes?
How will Trump’s trade talks end affect US-Canada relations?
What drove Nvidia’s recent stock rally to record highs?
Why is Warren Buffett donating billions in Berkshire shares?
How are AI developments impacting Wall Street trading?
Why did Nike stock soar despite tariff-related challenges?
What changes will the Supreme Court ruling on injunctions bring?
BeOne Medicines price target raised to $330 from $313 at Morgan Stanley
finance.yahoo.com/news/beone-medicines-price-target-raised-123543358.html
In This Article:
Morgan Stanley raised the firm’s price target on BeOne Medicines (ONC) to $330 from $313 and keeps an Overweight rating on the shares following the R&D day that highlighted the company’s pipeline programs. Management is targeting a 2026 approval for Sonrotoclax and 2027…
This story appeared on finance.yahoo.com, 2025-06-28 12:35:43.